Comparative analysis of HBV basic core promoter/pre-core gene mutations and viral quasispecies diversity in HIV/HBV co-infected and HBV mono-infected patients

被引:1
作者
Deng, Haohui [1 ,2 ,3 ]
Gao, Hongbo [3 ]
Liu, Yu [1 ,2 ]
Xu, Ying [1 ,2 ]
Yang, Juncheng [1 ,2 ]
Zhao, Miaoxian [1 ,2 ]
Liu, Huiyuan [3 ]
Wang, Zhanhui [1 ,2 ]
机构
[1] Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Guangdong Prov Key Lab Viral Hepatitis Res,Dept I, Guangzhou, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Peoples R China
[3] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Infect Dis Ctr, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
human immunodeficiency virus; hepatitis B virus; mutations; viral quasispecies; next-generation sequencing; HEPATITIS-B-VIRUS; COINFECTION; HIV; RESISTANCE;
D O I
10.4149/av_2022_103
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus (HIV)/hepatitis B virus (HBV) co-infection accelerates the progression of HBV-related liver diseases. HBV basic core promoter (BCP)/pre-core (preC) gene mutations may be one of the most important risk factors. In this study, a total of 230 patients were recruited, and 199 patients whose HBV BCP/preC gene were successfully amplified and sequenced, including 99 HIV/HBV co-infected and 100 HBV mono-infected patients. Next-generation sequencing was used for detection of BCP/preC mutations which were then compared in patients with different HBV genotypes and different HBeAg statuses, and 1% and 20% cutoff values were defined to evaluate the mutations. HBV quasispecies diversity was also compared in HIV/HBV co-infected and HBV mono-infected patients. Among the patients infected with HBV genotype C and HBeAg-negative status, the frequency of A1762T/G1764A double mutations was significantly lower in HIV/HBV co-infected patients than in HBV mono-infected patients (53.3% vs. 100.0%, P = 0.008) regardless of the 1% or 20% cutoff value level. However, A1762T/G1764A double mutations did not differ in the other groups (P >0.05). Viral quasispecies diversity was lower in HIV/HBV co-infected patients than in HBV mono-infected patients (P <0.05). This study revealed the characteristic of HBV BCP/preC gene mutations and viral quasispecies diversity in HIV/HBV co-infected patients.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 25 条
  • [1] Sanger sequencing versus INNO-LiPA® HBV PreCore assay for routine detection of precore and basal core promoter mutations in hepatitis virus B chronically infected patients
    Alidjinou, E. K.
    Bocket, L.
    Pigot, V.
    Lambert, V.
    Hallaert, C.
    Canva, V.
    Hober, D.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 90 (04) : 277 - 279
  • [2] HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing
    Audsley, Jennifer
    Littlejohn, Margaret
    Yuen, Lilly
    Sasadeusz, Joe
    Ayres, Anna
    Desmond, Christopher
    Spelman, Tim
    Lau, George
    Matthews, Gail V.
    Avihingsanon, Anchalee
    Seaberg, Eric
    Philp, Frances
    Saulynas, Melissa
    Ruxrungtham, Kiat
    Dore, Gregory J.
    Locarnini, Stephen A.
    Thio, Chloe L.
    Lewin, Sharon R.
    Revill, Peter A.
    [J]. VIROLOGY, 2010, 405 (02) : 539 - 547
  • [3] Comparative analysis of hepatitis B virus genotype a molecular evolution in patients infected with HBV and in patients co-infected with HBV and HIV
    Cassino, L.
    Torres, C.
    Mbayed, V.
    Laufer, N.
    Campos, R. H.
    Quarleri, J.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (04) : 562 - 569
  • [4] Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: A 3-yr prospective study
    Cassino, Lucila
    Laufer, Natalia
    Salomon, Horacio
    Campos, Rodolfo
    Quarleri, Jorge
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2009, 46 (04) : 354 - 359
  • [5] Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection
    Chang, J. Judy
    Sirivichayakul, Sunee
    Avihingsanon, Anchalee
    Thompson, Alex J. V.
    Revill, Peter
    Iser, David
    Slavin, John
    Buranapraditkun, Supranee
    Marks, Pip
    Matthews, Gail
    Cooper, David A.
    Kent, Stephen J.
    Cameron, Paul U.
    Sasadeusz, Joe
    Desmond, Paul
    Locarnini, Stephen
    Dore, Gregory J.
    Ruxrungtham, Kiat
    Lewin, Sharon R.
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (15) : 7649 - 7658
  • [6] Dynamic changes of HCV genomes under selective pressure from DAAs therapy in relapsed patients
    Deng, Haohui
    Guo, Fengxia
    Yu, Weihua
    Li, Linghua
    Xia, Yang
    Guan, Yujuan
    Li, Jianping
    [J]. VIRUS RESEARCH, 2021, 302
  • [7] Clinical efficacy and safety in telbivudine- or tenofovir-treated hepatitis B e antigen-positive pregnant women
    Deng, Haohui
    Liang, Shuzhen
    Xu, Min
    Zhuo, Li
    Gao, Hongbo
    Chen, Keng
    Shi, Yuming
    Li, Huihui
    Jiao, Qian
    Lin, Liansheng
    Lei, Yan
    Liu, Huiyuan
    [J]. ANTIVIRAL THERAPY, 2020, 25 (01) : 33 - 41
  • [8] Challenges and Priorities in the Management of HIV/HBV and HIV/HCV Coinfection in Resource-Limited Settings
    Easterbrook, Philippa
    Sands, Anita
    Harmanci, Hande
    [J]. SEMINARS IN LIVER DISEASE, 2012, 32 (02) : 147 - 157
  • [9] Clinical implications of HIV and hepatitis B co-infection in Asia and Africa
    Hoffmann, Christopher J.
    Thio, Chloe L.
    [J]. LANCET INFECTIOUS DISEASES, 2007, 7 (06) : 402 - 409
  • [10] Chronic Hepatitis B and HIV Coinfection: a Continuing Challenge in the Era of Antiretroviral Therapy
    H. Nina Kim
    [J]. Current Hepatology Reports, 2020, 19 (4) : 345 - 353